(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BREAK THROUGH EMBRACE THE CHALLENGE WITH ONO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

BREAK THROUGH EMBRACE THE CHALLENGE WITH ONO

ST13

US500000079412652

Class

5, 44

Filing

79412652

Registration

8226557

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

08/10/2026

Trademark type

Combined

Nice classes

5, 44

Filing date

09/30/2024

Registration date

04/28/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/28/2026

Last transaction

08/10/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

03

Owner location

JP

Examiner

SMITH, BRENDAN K

Law office

L80

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the stylized black wording "BREAK THROUGH" with a blue rectangle behind it. Beneath is the stylized black wording "EMBRACE THE CHALLENGE WITH ONO".

Holders and representatives

Holders

ONO PHARMACEUTICAL CO., LTD.

Representatives

Lori S. Kozak Fox Rothschild LLP

Technical classification

Nice Classes

Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-cancer preparations; chemical preparations for sanitary purposes; chemical preparations for medicinal purposesfor cardiovascular disordersgenitourinary disordersgynecological diseases and obstetric diseasescancer and its metastasiseye disordersneurologic disorderspsychiatric disordersendocrine and metabolic disordersallergic disordersgastrointestinal disordersimmune diseases and autoimmune diseasesrespiratory diseasesmusculoskeletal and connective tissue disordersinfectious diseasesdermatologic disordershematological disorderinflammatory diseasesearnosedental and throat disordershepatic and biliary disordersAlzheimer's diseasediabetes and its complications; diagnostic preparations for medical purposes; medicines for veterinary purposes for the treatment of cardiovascular disordersgenitourinary disordersgynecological diseases and obstetric diseasescancer and its metastasiseye disordersneurologic disorderspsychiatric disordersendocrine and metabolic disordersallergic disordersgastrointestinal disordersimmune diseases and autoimmune diseasesrespiratory diseasesmusculoskeletal and connective tissue disordersinfectious diseasesdermatologic disordershematological disorderinflammatory diseasesearnosedental and throat disordershepatic and biliary disordersAlzheimer's diseasediabetes and its complications; medicated toiletry preparations; sanitary preparations for medical purposes; fungicides; sterilizing preparations; disinfectants for hygiene purposes; pharmaceutical preparations for the treatment and prevention of cardiovascular disordersgenitourinary disordersgynecological diseases and obstetric diseasescancer and its metastasiseye disordersneurologic disorderspsychiatric disordersendocrine and metabolic disordersallergic disordersgastrointestinal disordersimmune diseases and autoimmune diseasesrespiratory diseasesmusculoskeletal and connective tissue disordersinfectious diseasesdermatologic disordershematological disorderinflammatory diseasesearnosedental and throat disordershepatic and biliary disordersalzheimer's diseasediabetes and its complications; pharmaceutical preparations for cancer supportive care; anesthetic for surgical purposessedative and analgesic drugs; vaccines; reagent paper for medical purposes; vitamin preparations; candymedicated; cough pastilles for pharmaceutical purposes; mint for pharmaceutical purposes; chewing gum for medical purposes; lecithin for medical purposes; greases for medical purposes; cod liver oil; medicinal preparations for the mouth to be applied in the form of capsules; oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive medical plasters; bandages for dressings; liquid bandages for skin wounds; breast-nursing pads; cotton swabs for medical use; dental materialsdental sealantsadhesivesamalgamsceramicsabrasivescementsalloyswaxpolish; baby diapers; infant diapers; adult diapers; baby diaper covers; infant diaper covers; adult diaper covers; fly catching paper; mothproofing paper; lacteal flour for babies; glucose dietary supplements; lecithin dietary supplements; nutritional supplements; dietary supplements mainly consisting of seafood extracts in the form of powderspillscapsulesgranulesjellies or liquids; dietary supplements for humans; dietary fibre to aid digestion; lyophilized food adapted for medical purposes; lyophilized meat adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies being baby foods; food for babies; nutritional supplements for animals; dietary supplements for animals; semen for artificial insemination

Class 44

Beauty salon services; barber shop services; providing bath houses; massage and therapeutic shiatsu massage; chiropractic services; moxibustion; medical treatment of dislocated jointssprainbone fractures; bodywork therapy; acupuncture; provision of medical information and information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals via the Internet; provision of medical information relating to benefitsside effectsinteractions of pharmaceuticals and medications; provision of medical information about pharmaceutical products; medicalmedicinal and pharmaceutical consultancy; advisory services relating to diagnosticprophylactic and therapeutic properties of pharmaceutical products; provision of information on diagnosticprophylactic and therapeutic properties of pharmaceuticals and medical services through computer databases; medical testing for the collection of medical informationanalysis and provision of medical information for diagnostic or treatment purposes; medical testing; medical consultancy and diagnosis of cardiovascular disordersgenitourinary disordersgynecological diseases and obstetric diseasescancer and its metastasiseye disordersneurologic disorderspsychiatric disordersendocrine and metabolic disordersallergic disordersgastrointestinal disordersimmune diseases and autoimmune diseasesrespiratory diseasesmusculoskeletal and connective tissue disordersinfectious diseasesdermatologic disordershematological disorderinflammatory diseasesearnosedental and throat disordershepatic and biliary disordersAlzheimer's diseasediabetes and its complications via the Internet; online medical counseling services; remote monitoring of medical data for medical diagnosis and treatment; analysis and provision of clinical data of patients for diagnostic or treatment purpose; provision of medical information; physical examination services; providing information about diagnosticprophylactic and therapeutic properties of pharmaceuticalsmedical services and health; consultancy services relating to medical servicesdiagnosticprophylactic and therapeutic properties of pharmaceuticalshealth and dispensing of medications; consultancyadvisory and provision of information relating to weight reduction diet planningfood nutritional intake and health care; consultancyadvisory and provision of information relating to health care; managed health care services; provision of records of personal health information data such as weightbody fatbody temperaturenumber of stepssleeping hours and blood pressure; nutritional consultancy and advisory for preventing and decreasing obesity; provision of information about nutritional consultancy and advisory for preventing and decreasing obesity; dietary and nutritional guidance; animal breeding; veterinary services; beautification for animalsanimal grooming; nursing care; rental of medical apparatus and instruments

Publications

History of USPTO decisions and trademark events.

34 publications found

ES7R

TEAS SECTION 7 REQUEST RECEIVED

08/10/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/28/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

06/04/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/18/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

05/18/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/28/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

04/28/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/10/2026

PUBO

PUBLISHED FOR OPPOSITION

03/10/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/04/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/11/2026

XAEC

EXAMINER'S AMENDMENT ENTERED

02/04/2026

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/04/2026

GNEA

EXAMINERS AMENDMENT E-MAILED

02/04/2026

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/04/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/06/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/06/2026

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

01/06/2026

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

01/01/2026

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

10/15/2025

GNFR

FINAL REFUSAL E-MAILED

10/15/2025

CNFR

FINAL REFUSAL WRITTEN

10/15/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/11/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/11/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/11/2025

RFNT

REFUSAL PROCESSED BY IB

06/07/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/21/2025

RFRR

REFUSAL PROCESSED BY MPU

05/21/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/26/2025

CNRT

NON-FINAL ACTION WRITTEN

03/25/2025

DOCK

ASSIGNED TO EXAMINER

03/19/2025

MAFR

APPLICATION FILING RECEIPT MAILED

12/20/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/20/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/19/2024

Continuous trademark protection

Get notified about every new filing that threatens BREAK THROUGH EMBRACE THE CHALLENGE WITH ONO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.